Media

El Balad: FDA Chief: TrumpRx Marks Major Progress in Affordable Medication Access

Despite the optimism surrounding TrumpRx, skepticism exists among some patients. Sarah Wisniewski, a Maryland resident with multiple sclerosis, expressed doubts. She has faced challenges securing coverage for necessary medications, raising concerns about whether the program can effectively address the needs of patients like her.

Media

Bloomberg: Trump Drug Pricing Order Spurs Doubts With Staff Cuts, Tariffs

But Merith Basey, executive director of Patients For Affordable Drugs, said in a statement that the change wouldn’t lower costs, but “hand drug companies four additional years to price-gouge patients.”

Media

ICYMI: Patients For Affordable Drugs & Allies Deliver Over 200k Petition Signatures To PhRMA HQ Demanding Pharma CEOs Drop Lawsuits Against Medicare Negotiation

Patients Urge Drug Companies To Stop Attempts To Block Lower Negotiated Prices From Taking Effect WASHINGTON, D.C. — Patients For Affordable Drugs, alongside patient advocates and allies including Public Citizen, Social Security Works, and SPACEs in Action, gathered in Washington, D.C. to demand drug companies drop their lawsuits aimed at blocking Medicare from negotiating lower drug prices […]